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BACKGROUND: The U.S. EPA revised the Reproduction and Fertility Effects Test Guideline (OPPTS 870.3800/OECD
416) in 1998, adding numerous endpoints in an effort to incorporate new methodologies, improve the sensitivity for
detecting reproductive toxicants, and more efficiently utilize study animals. Many of these new endpoints have not been
used in regulatory reproductive toxicology studies prior to their inclusion in the test guidelines; thus, the Health and
Environmental Sciences Institute (HESI) of the International Life Sciences Institute (ILSI) initiated the Reproductive
Endpoints Project to examine the utility of these new endpoints. METHODS: This report provides a retrospective
analysis of 43 multi-generation studies (16 in Wistar rats, 27 in Sprague-Dawley rats) conducted according to the latest
version of the test guidelines. It focuses on vehicle (negative) control values (means and ranges) for the various
endpoints to examine inter-laboratory variability. RESULTS: Based on the compiled data, the most variable endpoints
across laboratories and their associated coefficients of variation (CV) for each generation were: percent abnormal sperm
(166–205%), testicular spermatid concentration (126–147%), postimplantation loss (97–104%), primordial follicle counts
(69%, only measured in P2 females), and epididymal sperm concentration (52–57%). Absolute and relative prostate and
thymus weights, weanling uterine weights, and anogenital distance had CVs of 25–50%. Sources of variability included
procedural differences between laboratories, inherent biological variability, and/or small sample sizes for some
endpoints. CONCLUSIONS: These inter-laboratory control data provide a means for laboratories to review their
performance on reproductive toxicity measures, and provide perspective for interpreting their own control data and data
from treated animals. Birth Defects Res (Part B) 86:470–489, 2009. r 2009 Wiley-Liss, Inc.
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INTRODUCTION
In 1998, the United States Environmental Protection
Agency (U.S. EPA) revised the Reproductive and Fertility
Effects Test Guideline (OPPTS 870.3800; multi-generation
studies), adding new endpoints in an effort to improve
the sensitivity of the study to detect reproductive
toxicants. In addition, regulators felt that additional
information could be gained along with more efficient
use of study animals. New endpoints that were added to
the study are listed in Table 1. The difficulty with the
addition of these new endpoints is that many of these
endpoints had not been used in a regulatory setting prior
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to their inclusion in the test guidelines, and their utility
remains unproven.
In 1997, the International Life Sciences Institute (ILSI)
Health Sciences Institute (HESI) sponsored a workshop
to discuss the new endpoints and their interpretation. At
that time, workshop participants agreed that it would be
advantageous to review data in B5 years after adopting
the new guidelines to determine whether improvement
in the sensitivity of the Reproductive and Fertility Effects
Test Guideline to detect reproductive toxicants had been
achieved.
Thus, a follow-up study was sponsored by the ILSI
HESI Developmental and Reproductive Toxicology
Committee to evaluate the utility of the new reproductive
endpoints added to the Reproduction and Fertility
Effects test guideline in 1998 (OPPTS 870.3800 or the
OECD 416 guideline adopted in 2001). As part of this
evaluation, the steering committee agreed to compile a
data set of inter-laboratory vehicle control values that
could be used by laboratories and regulators to establish
typical mean values and ascertain the normal variability
around the means for the new endpoints added to the
test guideline. The second goal of the HESI project,
evaluating the performance of the new endpoints relative
to more traditional endpoints, will be discussed in a
separate report.
In order to gather multi-generation study data for
review, industrial companies, trade groups, and contract
research laboratories were contacted and asked to submit
study data collected in accordance with the OPPTS
870.3800 (OECD 416) test guideline. Forty-four reports
from 11 companies were received. The data were entered
into a database to facilitate database-level analyses.
Results of these analyses were evaluated by a steering
committee comprised of experts from industry, govern-
ment, and academia. This report presents data on inter-
laboratory control values for the new endpoints, as well




Numerous laboratories known to conduct toxicity
studies according to the OPPTS 870 guidelines were
contacted to ascertain whether these laboratories could
submit data for review. Participating laboratories sub-
mitted data collected in accordance with the OPPTS
870.3800 and/or OECD 416 guidelines. Forty-four re-
ports from 11 companies were received. Companies were
asked to submit finalized study reports with summary
tables (i.e., summary data containing means and stan-
dard deviations [SD] for continuous variables, incidence
data for counted endpoints, and sample sizes). Due to the
volume of data contained in each multi-generation study,
individual animal data and appendices were not in-
cluded in the submissions. To insure confidentiality, the
text of the reports was modified to remove any chemical-
specific information (e.g., chemical identity, structure,
chemical class, etc.). The data were entered into a
database to facilitate database-level analyses. In addition,
companies were asked to answer one supplemental
question as to whether the test material affected the
reproductive system (i.e., organ weights or histopathol-
ogy) in a shorter term study. Results of these analyses
were evaluated by a steering committee comprised of
experts from industry, government, and academia.
Definitions
Generations are defined as P1: first-parental genera-
tion randomized and placed on study as young adults;
F1: first-generation offspring produced by the P1
parents; P2: second-parental generations selected from
a subset of the F1 offspring; and F2: second-generation
offspring produced by the P2 parents.
Data Analysis
Control values (means and ranges) for various
reproductive parameters were compiled from the
Table 1
New Endpoints Added to OPPTS 870.3800 in 1998 (or OECD 416 in 2001)
Adult female:
Evaluation of the estrous cycle for 3 weeks prior to mating in P1 and P2 females
Organ weights in P1 and P2 femalesa
Primordial follicle counts in P2 females
Postimplantation loss in P1 and P2 females
Expanded histopathology of parental reproductive organs
Adult male:
Organ weights in P1 and P2 malesa
Epididymal sperm counts in P1 and P2 males
Testicular spermatid counts in P1 and P2 males
Sperm motility in P1 and P2 males
Sperm morphology in P1 and P2 males
Expanded histopathology of parental reproductive organs
Offspring:
Puberty onset in F1/P2 males and females
Anogenital distance in F2 offspring if triggered by a change in sex ratio or age at puberty onset
Weanling organ weights (brain, spleen, and thymus) in the F1 and F2 offspring (1 pup/sex/litter)b
Weanling necropsy with the examination of 3 pups/sex/litter compared with 1 pup/sex/litter required previously
Histopathological examination of treatment-related macroscopic abnormalities in weanlings
aReproductive organs, brain, pituitary, liver, kidneys, adrenals, spleen, and target organs.
bWeanling uterine weight was added as an endpoint by the Japanese Ministry of Forestry and Fisheries (JMAFF) in 2002.
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database; thus, the mean values reported in Tables 3–16
are the mean of the study means given in each
report. The standard deviations represent the variance
of mean values across studies. Data were analyzed
separately by strain as either Sprague-Dawley-derived
(Crl:CDs(SD)IGS BR, Crl:CDs(SD)IGS BR–VAF/Pluss,
Crl:CD (SD), Crl:CDs (SD) BR, Crl:CDs BR, Crl:CDs
BR–VAF/Pluss, CDs [Sprague-Dawley-derived]) or
Wistar-derived (CrlGlxBrlHan:WI, Chbb 5 THOM [SPF]).
When presenting inter-laboratory control values, minimum,
maximum, and percentile values were given so that the
reader might understand the distribution of the mean
values across studies. Data are presented as mean,
minimum value, 25th percentile, median (50th percen-
tile), 75th percentile, and maximum value. Thus, the
minimum value is the lowest mean reported across
studies, the maximum value is the highest mean reported
across studies, and so on. Percentile values are not
interpolated, but rather represent actual values at the
defined percentiles.
RESULTS AND DISCUSSION
Inter-Laboratory Control Data: General Principles
Data from Reproductive and Fertility Guideline stu-
dies (OPPTS 870.3800/OECD 416) were entered into a
database and summary control data (means and var-
iances) were calculated by strain (Sprague-Dawley- or
Wistar-derived). There were 44 studies submitted to the
data set: 27 for Sprague-Dawley-derived rats, 16 studies
for Wistar-derived rats, and 1 study for Alpk:APfSD rats.
For each set of endpoints, data for Sprague-Dawley-
derived rats appear in Table 1 followed by data for
Table 3
Control Values: Male Reproductive Parameters in Sprague-Dawley-Derived Rats
Endpoint Gen. n Mean SD Min 25% Median (50%) 75% Max
Fertility index (%) P1 27 89.1 6.6 73.3 86.4 90.0 93.3 100.0
P2 27 86.4 8.6 65.5 80.0 86.7 93.3 100.0
Mating index (%) P1 27 95.7 5.4 80.0 93.3 96.7 100.0 100.0
P2 27 94.7 4.7 82.8 93.3 96.7 96.7 100.0
Age at puberty onset (d) P1 – – – – – – – –
P2 27 45.3 2.1 41.2 43.6 45.2 47.0 49.0
Body weight at PPS (g) P1 – – – – – – – –
P2 15 210.9 39.7 118.9 207.6 227.0 233.3 240.7
Conc. epid. sperm (no.  106/g) P1 19 609.9 318.2 6.4 444.1 476.2 906.7 1,144.0
P2 18 595.7 337.6 8.2 420.8 506.6 791.0 1,189.4
Conc. test. sperm. (no.  106/g) P1 17 142.2 178.6 72.9 80.5 91.6 124.6 826.5
P2 17 159.5 235.1 76.2 85.7 93.2 133.5 1,063.9
Sperm motility (%) P1 23 82.2 11.3 50.9 82.8 85.5 89.0 93.1
P2 23 82.7 9.3 55.0 79.9 85.9 87.7 96.2
Abnormal sperm (%) P1 14 2.6 4.2 0.0 0.1 1.1 3.1 15.9
P2 14 3.8 7.8 0.0 0.2 0.9 3.6 30.0
Table 2






Endpoint 1st Gen. 2nd Gen. 1st Gen. 2nd Gen.
% Abnormal sperm X X
Testicular spermatid concentration X X
Epididymal sperm concentration X X
Post implantation loss X X
Primordial follicle counts NA X
Prostate Wts (abs) E X E
Prostate Wts (rel) X X
Thymus Wts (abs), female adults X X
Thymus Wts (abs), male adults E E E E
Thymus Wts (rel), female adults X X
Thymus Wts (rel), male adults X X
Based on a subset of data for Sprague-Dawley rats from laboratories that reported results for multiple studies. X identifies whether intra-
or inter-laboratory variability was greatest for each endpoint for each generation. E identifies values in which intra- and inter-
laboratory variability were similar (i.e., r12% difference). Shaded boxes identify consistent results across generations. NA 5 not
applicable; primordial follicle counts required in P2 females only.
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Wistar-derived rats (e.g., male reproductive parameters
for Sprague-Dawley and Wistar rats are reported in
Tables 3 and 4, respectively). Due to the limited number
of studies submitted, data for Alpk:APfSD rats are not
presented. As noted by the sample sizes in the various
data tables, means and variances were not reported for
all endpoints in all of the submitted studies.
To compile the database, the mean value for each
continuous endpoint was collated from each submitted
study. In order to clearly represent the mean values in the
data set, tables include a presentation of the mean (i.e.,
mean of the compiled means), median of the compiled
mean values, minimum study mean, and maximum
study mean values for each endpoint, as well as other
percentile values in the distribution of the study means.
The data distribution can be used to glean information on
the frequency with which values appear and, hence, how
typical a value is likely to be. In cases where the mean
and median are similar, this suggests that the data are more
evenly distributed. However, in some cases, the mean and
median differ. For example, the mean for abnormal sperm
is 2.56 and 3.80% for the first (P1) and second (P2) parental
generations, respectively, whereas the median values for
these generations are 1.05 and 0.90%, respectively (Table 3,
discussed in greater detail below). In this case, the mean
value is similar to the 75th percentile value, both of which
differ markedly from the maximum values (15.9–30%).
This disparity between the 75th percentile and the
maximum values suggests that such extreme maximum
values were not common across laboratories.
Table 5
Control Values: Female Reproductive Parameters in Sprague-Dawley-Derived Rats
Endpoint Gen. n Mean SD Min 25% Median (50%) 75% Max
Fertility index (%) P1 27 89.8 5.9 73.3 88.6 91.7 93.3 96.7
P2 27 87.5 7.7 72.4 80.0 89.7 93.3 100.0
Gestation index (%) P1 18 99.2 2.6 89.5 100.0 100.0 100.0 100.0
P2 18 99.0 1.9 95.2 100.0 100.0 100.0 100.0
Mating index (%) P1 27 96.2 4.4 86.7 93.3 96.7 100.0 100.0
P2 27 94.8 4.7 82.8 93.3 96.7 96.7 100.0
Postimplantation loss P1 7 4.9 5.0 0.5 1.0 1.2 8.6 12.2
P2 7 3.9 3.7 0.7 0.9 1.2 7.3 8.4
Age at puberty onset (d) P1 – – – – – – – –
P2 27 33.5 1.9 29.0 32.3 33.7 34.3 38.8
Body weight at VO (g) P1 – – – – – – – –
P2 15 124.8 40.4 90.5 105.7 109.1 124.7 223.0
Estrous cycle length (d) P1 18 4.4 0.3 4.1 4.2 4.3 4.5 5.3
P2 18 4.4 0.3 4.0 4.3 4.3 4.5 5.5
Time to mating (d) P1 18 2.9 0.6 1.8 2.5 2.8 3.1 4.4
P2 18 3.1 0.5 2.4 2.7 3.0 3.4 4.0
Gestational length (d) P1 25 22.1 0.4 21.6 21.8 22.0 22.3 23.2
P2 26 22.1 0.4 21.5 21.8 22.0 22.4 22.9
Primordial follicle count (total) P1 – – – – – – – –
P2 19 116.1 80.2 10.7 89.0 114.6 146.5 384.0
Table 4
Control Values: Male Reproductive Parameters in Wistar-Derived Rats
Endpoint Gen. n Mean SD Min 25% Median (50%) 75% Max
Fertility index (%) P1 16 95.3 5.4 84.0 92.0 96.3 100.0 100.0
P2 16 94.4 4.5 87.0 91.5 95.8 97.0 100.0
Mating index (%) P1 16 98.7 2.8 90.0 99.2 100.0 100.0 100.0
P2 16 98.7 2.0 95.8 96.0 100.0 100.0 100.0
Age at puberty onset (d) P1 – – – – – – – –
P2 17 43.5 1.4 40.9 42.8 43.6 44.0 47.1
Body weight at PPS (g) P1 – – – – – – – –
P2 7 162.7 31.3 92.2 170.0 174.2 176.1 180.6
Conc. epid. sperm (no.  106/g) P1 14 569.8 81.2 451.0 513.3 575.5 638.0 697.0
P2 14 608.5 88.8 444.0 548.5 641.0 674.8 705.0
Conc. test. sperm. (no.  106/g) P1 14 102.6 18.8 55.0 95.5 102.5 112.8 131.0
P2 14 108.3 18.5 82.0 96.0 107.5 119.5 144.0
Sperm motility (%) P1 17 87.3 3.3 81.0 85.9 89.0 90.0 91.0
P2 17 86.9 4.1 78.1 84.0 87.0 90.0 93.0
Abnormal sperm (%) P1 15 2.8 1.1 1.7 2.0 2.1 3.3 5.2
P2 16 2.2 0.8 1.0 1.6 2.4 2.7 3.5
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For some endpoints, variance (as measured by SD)
exceeded 20% of the mean value within the same
generation, resulting in relatively large coefficients of
variation (CV). These ‘‘high variability’’ endpoints in
Sprague-Dawley-derived rats included: postimplantation
loss (CV 97–104%), epididymal sperm concentration (CV
52–57%), testicular spermatid concentration (CV 126–147%),
percent abnormal sperm (CV 166–205%), primordial
follicle count (total) (CV 69%), anogenital distance (CV
28% in males, 42% in females), prostate weights (CV 29–
38%), thymus weights (CV 29–35% in males, 14–32% in
females), and weanling uterine weights (CV 16–52%).
Table 7
Control Values: P1 and P2 Reproductive Organ Weights for Adult Sprague-Dawley-Derived Rats
Endpoint Gen. n Mean SD Min 25% Median (50%) 75% Max
Males
Rel. epididymides wt (mean unilateral) (%) P1 18 0.131 0.009 0.117 0.125 0.131 0.138 0.154
P2 18 0.127 0.009 0.112 0.122 0.125 0.131 0.150
Epididymides weight (mean unilateral) (g) P1 26 0.738 0.038 0.683 0.716 0.737 0.740 0.838
P2 26 0.734 0.042 0.630 0.716 0.739 0.748 0.879
Rel. prostate wt (%) P1 18 0.186 0.063 0.105 0.133 0.184 0.227 0.312
P2 18 0.177 0.051 0.089 0.128 0.182 0.211 0.272
Prostate weight (g) P1 18 1.063 0.400 0.592 0.758 1.030 1.219 2.155
P2 18 1.039 0.321 0.527 0.810 1.130 1.239 1.652
Rel. sem. ves. wt (%) P1 18 0.413 0.075 0.252 0.363 0.423 0.470 0.522
P2 18 0.387 0.073 0.272 0.322 0.403 0.436 0.511
Sem. ves. weight (g) P1 18 2.331 0.406 1.627 2.012 2.326 2.639 2.908
P2 18 2.234 0.354 1.668 1.958 2.320 2.449 2.855
Rel. testes weight (mean unilateral) (%) P1 18 0.315 0.022 0.268 0.306 0.312 0.333 0.348
P2 18 0.313 0.015 0.297 0.301 0.308 0.323 0.349
Testes weight (mean unilateral) (g) P1 18 1.782 0.076 1.667 1.735 1.753 1.829 1.990
P2 18 1.822 0.101 1.629 1.761 1.843 1.872 2.069
Females
Rel. ovarian wt (mean unilateral) (%) P1 21 0.019 0.003 0.015 0.017 0.018 0.022 0.025
P2 22 0.019 0.003 0.016 0.017 0.018 0.020 0.027
Ovarian weight (mean unilateral) (g) P1 21 0.061 0.008 0.052 0.055 0.060 0.066 0.081
P2 23 0.062 0.008 0.050 0.057 0.060 0.066 0.081
Rel. uterine wt (%) P1 18 0.213 0.039 0.164 0.183 0.214 0.229 0.309
P2 19 0.204 0.037 0.140 0.173 0.209 0.231 0.266
Uterine wt (g) P1 18 0.671 0.116 0.490 0.580 0.660 0.717 0.970
P2 20 0.650 0.103 0.493 0.565 0.635 0.721 0.850
Table 6
Control Values: Female Reproductive Parameters in Wistar-Derived Rats
Endpoint Gen. n Mean SD Min 25% Median (50%) 75% Max
Fertility index (%) P1 16 95.2 7.0 75.0 92.0 98.3 100.0 100.0
P2 16 95.4 4.6 87.0 91.9 95.9 100.0 100.0
Gestation index (%) P1 16 99.0 1.8 96.0 99.0 100.0 100.0 100.0
P2 16 99.7 1.3 95.0 100.0 100.0 100.0 100.0
Mating index (%) P1 16 98.7 2.8 90.0 99.2 100.0 100.0 100.0
P2 16 98.7 2.0 95.8 96.0 100.0 100.0 100.0
Postimplantation loss P1 8 1.4 1.4 0.3 0.4 0.8 1.9 4.2
P2 8 1.2 0.7 0.4 0.8 1.0 1.4 2.5
Age at puberty onset (d) P1 – – – – – – – –
P2 17 32.6 1.8 29.9 31.5 32.0 34.1 35.3
Body weight at VO (g) P1 – – – – – – – –
P2 7 103.5 28.6 90.7 91.5 92.4 95.2 168.1
Estrous cycle length (d) P1 16 4.2 0.4 3.9 4.0 4.1 4.3 5.3
P2 16 4.4 0.5 3.6 4.1 4.2 4.6 5.5
Time to mating (d) P1 15 2.7 0.2 2.3 2.6 2.7 2.9 3.1
P2 15 2.5 0.5 1.9 2.2 2.3 2.6 3.7
Gestational length (d) P1 16 22.0 0.2 21.8 21.8 21.9 22.0 22.3
P2 16 22.0 0.1 21.8 21.9 22.0 22.1 22.3
Primordial follicle count (total) P1 – – – – – – – –
P2 15 165.1 57.4 51.3 150.5 169.0 196.5 250.0
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There are numerous factors that contribute to data
variability. First, there is inherent biological variability
in an endpoint, resulting in diverse values within and
across laboratories. Second, different laboratories may
use different procedures to evaluate some of the end-
points, thereby contributing to variability in the values
across laboratories. In addition, there are differences
across laboratories in the ages of the animals, source of
animals and animal diets used, among other factors.
A combination of these factors is likely. Additional
discussion of some factors that contribute to specific
endpoint variability is included below.
To examine potential sources of variability, the contribu-
tions of inter-laboratory and intra-laboratory variability
were examined for highly variable endpoints using
analysis of variance (ANOVA). The intra-laboratory
variability was equal to the mean square error (MSE),
whereas the inter-laboratory variability was equal to
[(model mean squareMSE)/number of observations per
laboratory]. Due to the larger number of studies
available, data for Sprague-Dawley rats from laboratories
that reported multiple studies were used for this
comparison. The intra-laboratory variability represents
variability contributed by both inherent biological varia-
bility and procedural differences in sampling across
studies conducted in the same laboratory. Presumably,
procedural differences within the same laboratory are
minimal if laboratories have documented standard
operating procedures (SOPs). The inter-laboratory varia-
bility for each endpoint represents procedural differ-
ences across laboratories as inherent biological variability
is accounted for in the intra-laboratory measurement. If
an endpoint is highly variable across laboratories, this
may suggest that some performance criteria are needed
to insure adequate data collection (e.g., standardize the
number of animals and/or sections examined for ovarian
follicle counts). As shown in Table 2, inter-laboratory
procedural differences appear to account for the majority
of variability in postimplantation loss, percent abnormal
sperm, and epididymal sperm concentration. In contrast,
inherent biological variability appears to account for
greater variance in testicular spermatid concentration
and primordial follicle counts. Intra-laboratory variabil-
ity was shown to impact absolute prostate weights in
P2 adult males, although intra- and inter-laboratory
differences both contributed to differences in prostate
weights in P1 males. For some endpoints (relative
prostate weights; absolute and relative thymus weights),
it was difficult to resolve whether intra- or inter-
laboratory differences contributed more to variability as
the results differed across generations. There were
insufficient laboratories reporting anogenital distance
and weanling uterine weights to allow a comparison for
these endpoints.
Observations on Specific Endpoints
Mating and Fertility Indices. Male reproductive
parameters in Sprague-Dawley- and Wistar-derived rats
are presented in Tables 3 and 4, respectively, and female
reproductive parameters are presented in Table 5
(Sprague-Dawley) and 6 (Wistar). For this assessment,
it was assumed that reproductive indices were calculated
using equations similar to those outlined in Foster (1999).
In both Sprague-Dawleys and Wistars, mating, fertility,
and gestation indices were generally high (mean486%).
Table 8
Control Values: P1 and P2 Reproductive Organ Weights for Adult Wistar-Derived Rats
Endpoint Gen. n Mean SD Min 25% Median (50%) 75% Max
Males
Rel. epididymides wt (mean unilateral) (%) P1 17 0.145 0.012 0.120 0.139 0.145 0.153 0.168
P2 17 0.144 0.012 0.123 0.136 0.141 0.154 0.165
Epididymides weight (mean unilateral) (g) P1 17 0.637 0.061 0.556 0.580 0.648 0.690 0.723
P2 17 0.634 0.051 0.542 0.586 0.656 0.672 0.704
Rel. prostate wt (%) P1 17 0.260 0.033 0.179 0.254 0.263 0.277 0.313
P2 17 0.241 0.031 0.168 0.234 0.248 0.260 0.290
Prostate weight (g) P1 17 1.141 0.157 0.959 1.031 1.073 1.264 1.432
P2 17 1.063 0.143 0.800 0.966 1.058 1.156 1.318
Rel. sem. ves. wt (%) P1 17 0.295 0.024 0.245 0.282 0.296 0.309 0.330
P2 17 0.278 0.024 0.244 0.258 0.275 0.298 0.319
Sem. ves. weight (g) P1 17 1.313 0.211 1.001 1.145 1.312 1.423 1.860
P2 17 1.231 0.164 1.040 1.136 1.207 1.283 1.740
Rel. testes weight (mean unilateral) (%) P1 17 0.417 0.045 0.330 0.409 0.420 0.453 0.485
P2 17 0.432 0.052 0.330 0.398 0.429 0.476 0.536
Testes weight (mean unilateral) (g) P1 17 1.829 0.075 1.696 1.767 1.831 1.884 1.948
P2 17 1.890 0.051 1.816 1.843 1.888 1.911 2.001
Females
Rel. ovarian wt (mean unilateral) (%) P1 17 0.023 0.003 0.018 0.021 0.024 0.025 0.027
P2 17 0.023 0.002 0.018 0.022 0.024 0.025 0.027
Ovarian weight (mean unilateral) (g) P1 17 0.059 0.007 0.048 0.053 0.057 0.062 0.073
P2 17 0.060 0.008 0.047 0.054 0.059 0.064 0.076
Rel. uterine wt (%) P1 17 0.266 0.040 0.189 0.239 0.267 0.297 0.327
P2 17 0.264 0.040 0.186 0.244 0.272 0.292 0.324
Uterine wt (g) P1 17 0.688 0.102 0.533 0.624 0.652 0.720 0.864
P2 17 0.686 0.131 0.483 0.626 0.672 0.725 0.980
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However, reproductive capacity exhibited some varia-
bility in control animals as illustrated by the minimum
values for the fertility indices.
There were some reproductive endpoints that were not
consistently reported. Gestation index (Number of
females with live born/Number of females pregnant
 100) was the reproductive index least likely to be
reported (34 of 44 laboratories reported this measure),
although it is required in the Test Reporting section of
OPPTS 870.3800. This reporting omission may not pose
an issue as gestation index is unlikely to be a sensitive
indicator of reproductive toxicity (i.e., a single live birth in
a litter is sufficient to include the dam in the numerator
for this calculation). Similarly, postimplantation loss
(Tables 5 and 6), which serves as an indicator of in utero
embryo/fetal loss, met the criterion for a highly variable
Table 9
Control Values: Additional P1 and P2 Organ Weights for (A) Adult Male and (B) Adult Female, Sprague-Dawley-
Derived Rats
Endpoint Gen. n Mean SD Min 25% Median (50%) 75% Max
(A) Males
Relative adrenal wt (%) P1 18 0.011 0.002 0.008 0.010 0.011 0.012 0.014
P2 18 0.011 0.001 0.009 0.010 0.010 0.011 0.014
Adrenal weight (g) P1 18 0.061 0.005 0.048 0.059 0.061 0.064 0.068
P2 18 0.062 0.005 0.054 0.058 0.062 0.065 0.071
Relative brain wt (%) P1 18 0.383 0.035 0.320 0.362 0.388 0.400 0.450
P2 18 0.410 0.092 0.334 0.362 0.373 0.404 0.637
Brain weight (g) P1 18 2.163 0.077 2.020 2.113 2.150 2.214 2.310
P2 18 2.150 0.069 2.040 2.114 2.135 2.169 2.300
Relative pituitary wt (%) P1 14 0.0025 0.0005 0.0020 0.0020 0.0024 0.0030 0.0030
P2 14 0.0025 0.0005 0.0020 0.0020 0.0026 0.0030 0.0030
Pituitary weight (g) P1 14 0.0143 0.0018 0.0110 0.0130 0.0144 0.0155 0.0176
P2 14 0.0146 0.0021 0.0090 0.0141 0.0152 0.0155 0.0170
Relative spleen wt (%) P1 18 0.148 0.006 0.137 0.145 0.148 0.150 0.163
P2 18 0.150 0.006 0.139 0.146 0.151 0.155 0.161
Spleen weight (g) P1 18 0.847 0.070 0.760 0.795 0.832 0.865 1.010
P2 18 0.878 0.066 0.760 0.850 0.867 0.915 1.000
Relative thymus wt (%) P1 11 0.049 0.014 0.032 0.041 0.043 0.056 0.077
P2 11 0.051 0.015 0.027 0.042 0.048 0.056 0.083
Thymus weight (g) P1 11 0.283 0.096 0.172 0.219 0.246 0.321 0.473
P2 11 0.297 0.104 0.155 0.232 0.281 0.342 0.520
Relative thyroid wt (%) P1 7 0.0047 0.0005 0.0040 0.0044 0.0048 0.0050 0.0055
P2 7 0.0046 0.0005 0.0039 0.0043 0.0046 0.0050 0.0050
Thyroid weight (g) P1 7 0.0264 0.0029 0.0234 0.0243 0.0250 0.0285 0.0308
P2 7 0.0271 0.0039 0.0224 0.0245 0.0272 0.0289 0.0336
(B) Females
Relative adrenal wt (%) P1 21 0.025 0.003 0.021 0.024 0.025 0.027 0.031
P2 22 0.025 0.003 0.022 0.023 0.025 0.027 0.034
Adrenal weight (g) P1 21 0.082 0.008 0.069 0.078 0.080 0.086 0.103
P2 23 0.083 0.011 0.070 0.074 0.080 0.090 0.112
Relative brain wt (%) P1 21 0.633 0.053 0.520 0.604 0.633 0.665 0.743
P2 22 0.589 0.104 0.329 0.574 0.613 0.637 0.766
Brain weight (g) P1 21 2.020 0.101 1.890 1.960 1.980 2.052 2.300
P2 23 2.018 0.104 1.880 1.940 1.977 2.091 2.220
Relative pituitary wt (%) P1 17 0.0055 0.0008 0.0040 0.0050 0.0060 0.0060 0.0070
P2 18 0.0053 0.0008 0.0040 0.0050 0.0051 0.0060 0.0070
Pituitary weight (g) P1 17 0.0175 0.0025 0.0120 0.0160 0.0180 0.0188 0.0219
P2 18 0.0171 0.0022 0.0120 0.0166 0.0171 0.0186 0.0199
Relative spleen wt (%) P1 21 0.196 0.013 0.173 0.184 0.195 0.206 0.224
P2 22 0.196 0.011 0.178 0.190 0.195 0.201 0.221
Spleen wt (g) P1 21 0.628 0.053 0.567 0.590 0.610 0.660 0.750
P2 23 0.638 0.051 0.577 0.606 0.630 0.645 0.760
Relative thymus wt (%) P1 13 0.078 0.013 0.056 0.073 0.078 0.081 0.107
P2 14 0.080 0.025 0.035 0.063 0.086 0.089 0.146
Thymus weight (g) P1 13 0.254 0.036 0.210 0.223 0.252 0.282 0.330
P2 15 0.260 0.083 0.121 0.205 0.253 0.296 0.484
Relative thyroid wt (%) P1 8 0.0066 0.0009 0.0056 0.0060 0.0062 0.0071 0.0080
P2 8 0.0063 0.0006 0.0057 0.0060 0.0061 0.0066 0.0073
Thyroid weight (g) P1 8 0.0200 0.0032 0.0164 0.0174 0.0190 0.0233 0.0240
P2 8 0.0203 0.0025 0.0166 0.0192 0.0200 0.0222 0.0238
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endpoint. This may be related to the relatively small n
value (n 5 7 or 8) for the numbers of laboratories
reporting postimplantation loss.
Time to mating, precoital interval (Tables 5 and 6), was
included in nearly all reports with Wistar rats (14 of 16),
whereas it was reported less frequently in Sprague-
Dawley studies (18 of 27). It appears that the time to
mating was slightly less in Wistar than Sprague-Dawley
rats (mean times 5 2.4–2.7 days in Wistar rats vs. 2.9–3.1
days in Sprague-Dawley rats). A related variable
‘‘number of estrous periods until mating’’ was seldom
reported although it is required per the test guideline.
This variable can be estimated from mean estrous cycle
length and days to mating.
Age at Puberty Onset. Age at puberty onset (as
well as mating and fertility indices and sperm para-
meters) is presented in Tables 3–6. Age at puberty onset
in the P2 generation was reported in all studies and
varied across a series of days in control animals from
both strains. Puberty onset is an apical endpoint that
Table 10
Control Values: Additional P1 and P2 Organ Weights for (A) Adult Male and (B) Adult Female Wistar-Derived Rats
Endpoint Gen. n Mean SD Min 25% Median (50%) 75% Max
(A) Males
Relative adrenal wt (%) P1 17 0.015 0.002 0.012 0.014 0.015 0.016 0.018
P2 17 0.015 0.001 0.013 0.015 0.016 0.016 0.018
Adrenal weight (g) P1 17 0.066 0.010 0.055 0.058 0.063 0.074 0.083
P2 17 0.069 0.008 0.058 0.062 0.064 0.077 0.084
Relative brain wt (%) P1 17 0.474 0.051 0.380 0.446 0.477 0.512 0.563
P2 17 0.477 0.053 0.370 0.438 0.486 0.521 0.568
Brain weight (g) P1 17 2.069 0.054 1.942 2.044 2.093 2.110 2.137
P2 17 2.086 0.047 1.975 2.074 2.101 2.123 2.136
Relative pituitary wt (%) P1 16 0.0027 0.0004 0.0020 0.0023 0.0030 0.0030 0.0030
P2 16 0.0025 0.0005 0.0020 0.0020 0.0022 0.0030 0.0030
Pituitary weight (g) P1 16 0.0112 0.0017 0.0090 0.0100 0.0104 0.0124 0.0150
P2 16 0.0108 0.0016 0.0090 0.0099 0.0102 0.0114 0.0150
Relative spleen wt (%) P1 17 0.172 0.018 0.149 0.161 0.165 0.179 0.216
P2 17 0.172 0.014 0.153 0.160 0.165 0.183 0.203
Spleen weight (g) P1 17 0.769 0.147 0.580 0.660 0.714 0.883 1.123
P2 17 0.772 0.156 0.609 0.650 0.699 0.889 1.165
Relative thymus wt (%) P1 8 0.073 0.030 0.044 0.050 0.058 0.101 0.116
P2 8 0.081 0.034 0.052 0.056 0.060 0.119 0.126
Thymus weight (g) P1 8 0.335 0.132 0.205 0.249 0.260 0.440 0.550
P2 8 0.367 0.128 0.246 0.276 0.295 0.505 0.546
Relative thyroid wt (%) P1 6 0.0057 0.0005 0.0050 0.0053 0.0060 0.0060 0.0060
P2 6 0.0057 0.0008 0.0050 0.0050 0.0055 0.0060 0.0070
Thyroid weight (g) P1 5 0.0225 0.0012 0.0206 0.0226 0.0226 0.0232 0.0237
P2 6 0.0230 0.0032 0.0193 0.0206 0.0229 0.0245 0.0280
(B) Females
Relative adrenal wt (%) P1 17 0.034 0.003 0.028 0.032 0.034 0.037 0.039
P2 17 0.035 0.003 0.029 0.033 0.035 0.036 0.039
Adrenal weight (g) P1 17 0.090 0.015 0.072 0.076 0.089 0.103 0.111
P2 17 0.091 0.014 0.072 0.079 0.092 0.103 0.114
Relative brain wt (%) P1 17 0.747 0.080 0.600 0.695 0.723 0.806 0.900
P2 17 0.755 0.079 0.610 0.691 0.744 0.821 0.879
Brain weight (g) P1 17 1.925 0.029 1.884 1.903 1.921 1.939 1.978
P2 17 1.936 0.041 1.818 1.920 1.930 1.965 2.001
Relative pituitary wt (%) P1 16 0.0054 0.0007 0.0040 0.0050 0.0055 0.0060 0.0060
P2 16 0.0050 0.0005 0.0040 0.0050 0.0050 0.0050 0.0060
Pituitary weight (g) P1 16 0.0138 0.0017 0.0110 0.0129 0.0136 0.0146 0.0176
P2 15 0.0130 0.0013 0.0108 0.0120 0.0129 0.0143 0.0149
Relative spleen wt (%) P1 17 0.217 0.016 0.191 0.206 0.213 0.226 0.248
P2 17 0.222 0.013 0.209 0.211 0.219 0.230 0.259
Spleen wt (g) P1 17 0.571 0.093 0.446 0.496 0.580 0.608 0.798
P2 17 0.580 0.092 0.460 0.524 0.550 0.630 0.823
Relative thymus wt (%) P1 8 0.093 0.008 0.082 0.088 0.095 0.097 0.104
P2 8 0.098 0.010 0.083 0.094 0.099 0.103 0.111
Thymus weight (g) P1 8 0.257 0.018 0.230 0.248 0.257 0.266 0.286
P2 8 0.267 0.020 0.235 0.252 0.271 0.284 0.288
Relative thyroid wt (%) P1 6 0.0070 0.0006 0.0060 0.0070 0.0070 0.0070 0.0080
P2 6 0.0080 0.0011 0.0060 0.0080 0.0080 0.0088 0.0090
Thyroid weight (g) P1 6 0.0169 0.0015 0.0141 0.0167 0.0173 0.0178 0.0183
P2 6 0.0187 0.0012 0.0169 0.0181 0.0186 0.0198 0.0200
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exhibits some inherent variability and can be influenced
by a number of factors (for review, see Goldman et al.,
2000; Stoker et al., 2000). Across submitted studies, the
mean ages at preputial separation (PPS; Tables 3 and 4)
ranged from 41.2–49.0 days in Sprague-Dawley rats and
40.9–45.0 days in Wistar rats, but overall CVs were low
(3–5%). Mean age at preputial separation was B2 days
earlier in Wistar rats than Sprague-Dawley rats. Addi-
tional variability may occur across laboratories, depend-
ing on how the age at preputial separation is classified
(i.e., as the age at which preputial separation has clearly
started or the age at which preputial separation is
completed). Similarly, mean ages at vaginal opening/
vaginal patency (VO/VP; Tables 5 and 6) varied from
29.0–38.8 in Sprague-Dawley rats and 29.9–35.1 in Wistar
rats. The CV was 6% in both strains. The mean age at
vaginal opening was one day earlier in Wistar rats than
Sprague-Dawley rats. One factor that may have con-
tributed to variability in determining the age of puberty
onset is the appearance of vaginal or preputial threads.
Based on the available data, it is difficult to determine
the incidence of these threads and whether they
contributed to later ages for puberty onset. Data from
animals with vaginal or preputial threads are likely to be
handled differently in different laboratories. In the
current inter-laboratory dataset, body weight measure-
ments were often not reported on the day at which
preputial separation or vaginal opening was achieved.
Table 11
Control Values: F1 and F2 Litter Sizes for Sprague-Dawley-Derived Rats
Endpoint Gen. n Mean SD Min 25% Median (50%) 75% Max
Litter size, PND 0 P1
All 23 13.74 0.94 12.30 13.00 13.60 14.35 15.90
Culled 18 13.61 1.01 12.30 12.93 13.45 14.35 15.90
Not culled 5 14.22 0.43 13.60 14.20 14.20 14.30 14.80
P2
All 23 13.77 0.96 12.50 13.00 13.60 14.20 16.40
Culled 18 13.74 1.06 12.50 13.00 13.50 14.05 16.40
Not culled 5 13.86 0.59 13.00 13.60 13.90 14.30 14.50
Litter size, PND 4 P1
All 12 13.27 1.22 11.20 12.60 13.05 13.98 15.70
Culled 7 12.80 1.41 11.20 12.15 12.70 12.85 15.70
Not culled 5 13.92 0.49 13.20 13.80 13.90 14.20 14.50
P2
All 12 13.37 1.03 11.90 12.80 13.20 13.85 15.90
Culled 7 13.29 1.28 11.90 12.80 12.90 13.35 15.90
Not culled 5 13.48 0.65 12.40 13.50 13.50 14.00 14.00
Litter size, PND 7 P1
Culled 7 7.70 0.21 7.40 7.55 7.80 7.80 8.00
Not culled 5 13.80 0.41 13.10 13.80 13.90 14.10 14.10
P2
Culled 7 7.74 0.14 7.50 7.70 7.80 7.80 7.90
Not culled 5 13.40 0.62 12.40 13.30 13.50 13.80 14.00
Litter size, PND 14 P1
Culled 7 7.64 0.29 7.20 7.45 7.80 7.80 8.00
Not culled 5 13.78 0.40 13.10 13.80 13.90 14.00 14.10
P2
Culled 7 7.73 0.16 7.50 7.65 7.80 7.80 7.90
Not culled 5 13.36 0.60 12.40 13.30 13.40 13.70 14.00
Litter size, PND 21
P1
Culled 7 7.64 0.29 7.20 7.45 7.80 7.80 8.00
Not culled 5 13.76 0.38 13.10 13.80 13.90 13.90 14.10
P2
Culled 7 7.73 0.16 7.50 7.65 7.80 7.80 7.90
Not culled 5 13.24 0.68 12.10 13.30 13.30 13.60 13.90
Table 12
Control Values: F1 and F2 Litter Sizes for Wistar-Derived Rats
Endpoint Gen. Studies n Mean SD Min 25% Median (50%) 75% Max
Litter size, PND 0
P1
All 17 11.84 1.88 9.10 10.60 10.90 13.50 15.20
Culled 15 11.67 1.91 9.10 10.45 10.80 13.30 15.20
P2
All 17 11.48 1.67 9.90 10.20 10.40 13.00 14.70
Culled 15 11.45 1.69 9.90 10.25 10.40 12.90 14.70
Litter size, PND 4
P1
All 14 11.36 2.03 7.80 10.10 10.65 12.95 14.50
Culled 12 11.30 2.15 7.80 10.03 10.60 13.08 14.50
P2
All 14 11.18 1.63 9.00 9.93 10.55 12.70 14.30
Culled 12 11.15 1.66 9.00 9.98 10.55 12.50 14.30
Litter size, PND 7 P1 Culled 12 7.74 0.20 7.30 7.68 7.80 7.90 8.00
P2 Culled 12 7.66 0.25 7.20 7.48 7.65 7.83 8.00
Litter size, PND 14 P1 Culled 12 7.70 0.17 7.30 7.68 7.75 7.80 7.90
P2 Culled 12 7.62 0.30 7.10 7.40 7.65 7.83 8.00
Litter size, PND 21 P1 Culled 12 7.68 0.16 7.30 7.60 7.70 7.80 7.90
P2 Culled 12 7.60 0.30 7.10 7.38 7.65 7.83 8.00
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Thus, it is difficult to determine how variable body
weights were across these datasets and how body weight
influenced the age ranges for preputial separation and
vaginal patency. Furthermore, there is evidence that the
amount of calories consumed in the diet will impact
puberty onset in female rats (Odum et al., 2004). There
are likely to be variations in the rodent diets (their energy
content as well as phytoestrogen levels) and even
bedding across laboratories, which may affect puberty
onset.
Sperm Parameters. In the 1998 guideline revision
to OPPTS 870.3800, sperm parameters were added as
endpoints to the reproduction and fertility effects study.
The addition of multiple sperm parameters was based on
the premise that toxicants with different modes of action
may affect sperm endpoints differentially, making
different endpoints more sensitive to different types of
toxicants. Inter-laboratory control values for testicular
spermatid and epididymal sperm concentrations, sperm
motility, and percent abnormal sperm are reported in
Tables 3 (Sprague-Dawley) and 4 (Wistar). Interestingly,
epididymal and testicular sperm/spermatid concentra-
tions and percent abnormal sperm were identified as
‘‘high variability’’ endpoints in Sprague-Dawley rats.
This variability could arise from multiple sources
including different procedures across laboratories and
inter-individual variability. Within the control popula-
tion, there is a background incidence of oligospermic
males, which contributes to this variability.
Sperm Motility: Variability in sperm motility may
result from numerous procedural differences between
laboratories. Sperm from the cauda epididymis or the vas
deferens are typically used and the method used to
release sperm may affect motility measurements (Chapin
and Conner, 1999). Differences in media used for sperm
motility assessments may affect these values across
Table 13
Control Values: F1 and F2 Pup Body Weights (g) for Sprague-Dawley-Derived Rats
Endpoint Gen. n Mean SD Min 25% Median (50%) 75% Max
Males
Body weight, PND 1 F1 17 7.1 0.28 6.6 6.9 7.1 7.2 7.8
F2 17 7.0 0.24 6.6 6.9 7.0 7.2 7.5
Body weight, PND 4 F1 20 10.2 0.69 9.1 9.7 10.2 10.5 11.6
F2 20 10.2 0.70 8.9 9.8 10.2 10.4 11.7
Body weight, PND 21a F1 13 54.3 4.8 45.4 50.6 54.6 58.5 60.5
F2 13 55.1 4.4 50.0 51.3 54.2 56.7 63.8
Anogenital distanceb F1 1 4.34
F2 9 3.83 1.07 2.56 2.80 4.32 4.41 5.30
Females
Body weight, PND 1 F1 17 6.7 0.28 6.2 6.5 6.7 6.8 7.3
F2 17 6.6 0.24 6.2 6.5 6.6 6.8 7.0
Body weight, PND 4 F1 20 9.7 0.70 8.5 9.3 9.6 9.9 11.1
F2 20 9.7 0.69 8.4 9.2 9.7 9.9 11.2
Body weight, PND 21a F1 13 52.0 4.1 44.1 49.2 52.1 55.6 57.6
F2 13 52.4 4.1 47.1 49.2 51.6 53.5 60.4
Anogenital distance (mm)b F1 1 2.41
F2 9 2.08 0.88 1.04 1.20 2.28 2.57 3.40
aExcludes 12 studies where litters were not culled (5) or for which the route of exposure was inhalation (7).
bAnogenital distance was recorded on PND 1; limited data for F2 PND 0 (n 5 1) and PND 4 (n 5 1) are not presented.
Table 14
Control Values: F1 and F2 Pup Body Weights (g) for Wistar-Derived Rats
Endpoint Gen. n Mean SD Min 25% Median (50%) 75% Max
Males
Body weight, PND 1 F1 17 6.3 0.26 5.8 6.1 6.4 6.5 6.8
F2 17 6.4 0.21 5.9 6.2 6.4 6.5 6.7
Body weight, PND 4 F1 17 9.4 0.44 8.7 9.1 9.4 9.7 10.2
F2 17 9.6 0.40 9.0 9.4 9.5 9.7 10.7
Body weight, PND 21a F1 15 48.1 3.20 42.0 46.0 47.5 50.9 52.8
F2 15 49.3 2.95 44.4 47.2 49.7 52.0 54.6
Females
Body weight, PND 1 F1 17 6.0 0.26 5.4 5.8 6.1 6.2 6.4
F2 17 6.0 0.18 5.7 5.9 6.1 6.1 6.3
Body weight, PND 4 F1 17 9.0 0.42 8.3 8.8 8.9 9.2 9.8
F2 17 9.2 0.40 8.6 9.0 9.2 9.3 10.3
Body weight, PND 21a F1 15 46.7 3.04 40.9 44.2 46.6 48.6 51.4
F2 15 47.4 2.70 42.6 45.4 47.7 49.8 51.6
aExcludes 2 studies that did not cull to 4 pups/sex/litter on PND 4.
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laboratories as some media may better support sperm
motility. Most laboratories use a computer-assisted
sperm analyzer (CASA, e.g., Hamilton-Thorne) to assess
motility, but parameter settings used to detect motile,
non-motile, and progressively motile sperm may vary
from laboratory to laboratory. The impact of different
variables on motility measurements (e.g., CASA para-
meters, temperature, pH, chamber size, sample density,
interval between necropsy, and motility assessment, etc.)
have been well described by Slott and Perreault (1993)
and Seed et al. (1996). Slott and Perreault (1993)
recommend that 200 sperm/sample be monitored during
motility assessments; however, the number of sperm to
evaluate is not specified in the test guidelines. As with all
methods, it is critical for laboratories to conduct sperm
motility assessments in a consistent manner within and
between studies.
With so many variables, comparison of motility data
across laboratories is difficult. Still, a minimum motility
value of 70% has been suggested as an acceptable level in
control rats (Seed et al., 1996; Chapin et al., 1992). While
this value has not been rigorously tested, only 3 of the 79
mean control values for sperm motility (P1 and P2 values
for both Sprague-Dawley and Wistar rats) were less than
70%. According to Chapin and Conner (1999), control
values of 85–96% are commonly reported in rat studies,
which is consistent with the median to maximum values
in Sprague-Dawley rats and the 25% to maximum values
in Wistar rats. Overall, sperm motility data had less
variability among laboratories than sperm morphology
and sperm/spermatid counts.
Interestingly, the guidelines require that the ‘‘number
and percent of progressively motile sperm’’ be reported
in each multi-generation study; however, few labora-
tories reported progressively motile sperm in their multi-
generation study data. The rationale for not reporting
progressively motile sperm may be related to the lack of
a scientifically agreed-upon definition as to what con-
stitutes ‘‘progressively motile.’’ When using CASA,
progressive motility depends on user-defined para-
meters for average path velocity and straightness of
linear index, values that likely differ from laboratory to
laboratory in those that choose to collect and report
progressive motility.
Epididymal sperm concentrations: There was re-
markable consistency in the practice of presenting sperm
count data as ‘‘counts per g tissue’’ in the multi-
generation study reports. Still, epididymal sperm con-
centration was considered a ‘‘highly variable’’ endpoint
with CVs greater than 50% in Sprague-Dawley rats. In
this strain, mean epididymal sperm concentrations
across studies ranged from 6.4 million to 1,144 million
sperm/g cauda epididymis (P1) and from 8.2 million to
1,189.4 million sperm/g cauda epididymis (P2). In Wistar
rats, epididymal sperm concentration variability was
much lower, ranging from 451 million to 697 million and
Table 15
Control Values: F1 and F2 Pup Organ Weights for Sprague-Dawley-Derived Ratsa
Endpoint Gen. n Mean SD Min 25% Median (50%) 75% Max
Males
Relative brain wt (%) F1 14 2.707 0.317 1.860 2.557 2.754 2.937 3.084
F2 13 2.661 0.290 1.830 2.626 2.683 2.803 3.088
Brain weight (g) F1 14 1.481 0.049 1.364 1.469 1.500 1.503 1.553
F2 13 1.500 0.042 1.445 1.474 1.490 1.520 1.593
Relative spleen wt (%) F1 14 0.437 0.031 0.364 0.419 0.434 0.463 0.478
F2 13 0.428 0.031 0.363 0.407 0.431 0.440 0.471
Spleen weight (g) F1 14 0.245 0.032 0.197 0.222 0.246 0.269 0.305
F2 13 0.246 0.028 0.216 0.223 0.239 0.256 0.317
Relative thymus wt (%) F1 14 0.425 0.039 0.371 0.402 0.410 0.439 0.508
F2 13 0.432 0.037 0.384 0.407 0.421 0.448 0.500
Thymus weight (g) F1 14 0.239 0.038 0.183 0.212 0.234 0.257 0.312
F2 13 0.248 0.037 0.206 0.233 0.245 0.251 0.351
Females
Relative brain wt (%) F1 13 2.756 0.299 1.970 2.643 2.809 2.911 3.153
F2 13 2.700 0.298 1.890 2.660 2.741 2.846 3.173
Brain weight (g) F1 14 1.435 0.041 1.339 1.422 1.437 1.460 1.491
F2 13 1.447 0.037 1.389 1.420 1.438 1.465 1.527
Relative spleen wt (%) F1 13 0.448 0.046 0.361 0.421 0.443 0.486 0.531
F2 13 0.446 0.035 0.358 0.432 0.448 0.475 0.492
Spleen wt (g) F1 14 0.239 0.029 0.190 0.225 0.242 0.256 0.294
F2 13 0.244 0.024 0.216 0.226 0.240 0.261 0.292
Relative thymus wt (%) F1 13 0.458 0.034 0.410 0.435 0.444 0.479 0.522
F2 13 0.460 0.040 0.414 0.425 0.456 0.464 0.548
Thymus weight (g) F1 14 0.244 0.031 0.188 0.228 0.245 0.252 0.311
F2 13 0.251 0.034 0.208 0.234 0.247 0.257 0.337
Relative uterine wt (%) F1 3 0.098 0.016 0.087 0.091 0.116
F2 3 0.072 0.016 0.062 0.065 0.091
Uterine weight (g) F1 3 0.061 0.024 0.047 0.048 0.088
F2 3 0.046 0.024 0.031 0.035 0.074
aExcludes 12 studies where litters were not culled (5) or for which the route of exposure was inhalation (7).
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from 444 million to 705 million sperm/g cauda epididy-
mis in the P1 and P2 generations, respectively. This may
be due to fewer laboratories reporting data in Wistar rats,
which supports the ANOVA analysis results (i.e., that
inter-laboratory variability makes a greater contribution
to differences in sperm concentrations than inherent
variability). Aside from methodological differences,
other factors also may influence sperm concentrations,
such as the age of the rats at the time the sample was
collected, and the timing of the necropsy and sperm
sampling relative to the last (successful) mating day
(because epididymal sperm may be depleted due to
recent ejaculatory activity). In these multi-generation
studies, necropsy of the males may occur at different
time points after the required 12-week dosing period,
particularly if a second breeding is required. Further-
more, strain differences in sperm counts have
been reported (Chapin and Conner, 1999) and some
variability in sperm counts has been documented
(Morrissey et al., 1988).
Despite this variability, sperm concentration may offer
value in assessing male reproductive toxicity. Sperm
count has been definitively linked to fertility in all
species studied. Chapin et al. (1997) showed that a 10%
reduction in sperm counts was reflected as a change in
mouse fertility across studies in the National Toxicology
Program Continuous Breeding database. Power calcula-
tions estimate a 90% chance of detecting a 15% change in
epididymal sperm count when n 5 20 per group (Chapin
and Conner, 1999) and a 31–32% change when n 5 15 in
rats (Blazak et al., 1985). Histological changes in the testis
may correlate with altered epididymal sperm counts, but
evidence exists to indicate that these parameters may be
altered independent of one another (Chapin and Conner,
1999).
Testicular spermatid concentrations: As with the
epididymal sperm concentration, the testicular homo-
genization-resistant spermatid head concentration was
considered a ‘‘highly variable’’ endpoint with CVs
greater than 125% in Sprague-Dawley rats. Spermatid
concentrations (spermatids/g testis) ranged from 72.9 to
826.5 in the P1 generation and from 76.2 to 1,063.9 in the
P2 generation in this strain. Similarly, Wistar rats had less
variability in spermatid concentrations than Sprague-
Dawley rats. Both inherent biological variability and
methodological differences appear to contribute to the
high degree of variability in this endpoint; however,
inherent biological and/or intra-laboratory procedural
factors contribute most to variability (Table 2).
Mean spermatid counts/g testicular tissue
(mean 5 142.2159.5 106 for Sprague-Dawley-derived
rats; 106.2109.2 106 for Wistar-derived rats) were
similar to previously reported spermatid concentrations
in both strains (e.g., Tyl et al., 2004; Willoughby et al.,
2000; Schneider et al., 2005; Suter et al., 1998). Despite this
variability, spermatid counts generally are considered to
Table 16
Control Values: F1 and F2 Pup Organ Weights for Wistar-Derived Ratsa
Endpoint Gen. n Mean SD Min 25% Median (50%) 75% Max
Males
Relative brain wt (%) F1 15 3.071 0.223 2.697 2.904 3.139 3.205 3.359
F2 15 3.051 0.199 2.710 2.887 3.049 3.200 3.419
Brain weight (g) F1 15 1.481 0.029 1.412 1.460 1.491 1.499 1.528
F2 15 1.494 0.020 1.458 1.486 1.495 1.500 1.540
Relative spleen wt (%) F1 15 0.453 0.026 0.416 0.434 0.443 0.470 0.503
F2 15 0.466 0.023 0.423 0.450 0.472 0.484 0.498
Spleen weight (g) F1 15 0.223 0.022 0.183 0.210 0.226 0.236 0.259
F2 15 0.232 0.013 0.214 0.222 0.235 0.240 0.260
Relative thymus wt (%) F1 15 0.415 0.053 0.319 0.364 0.434 0.443 0.485
F2 15 0.421 0.057 0.332 0.354 0.452 0.465 0.477
Thymus weight (g) F1 15 0.201 0.018 0.170 0.193 0.206 0.211 0.240
F2 15 0.208 0.021 0.174 0.191 0.216 0.227 0.229
Females
Relative brain wt (%) F1 15 3.093 0.197 2.777 2.921 3.152 3.229 3.340
F2 14 3.075 0.184 2.838 2.915 3.088 3.208 3.411
Brain weight (g) F1 15 1.435 0.026 1.377 1.415 1.443 1.454 1.465
F2 15 1.445 0.018 1.415 1.429 1.448 1.463 1.467
Relative spleen wt (%) F1 15 0.463 0.020 0.437 0.447 0.461 0.474 0.503
F2 14 0.474 0.028 0.429 0.457 0.471 0.497 0.520
Spleen wt (g) F1 15 0.218 0.016 0.193 0.207 0.220 0.232 0.241
F2 15 0.226 0.011 0.205 0.218 0.228 0.233 0.243
Relative thymus wt (%) F1 15 0.440 0.056 0.342 0.386 0.461 0.476 0.520
F2 14 0.447 0.069 0.349 0.368 0.483 0.492 0.522
Thymus weight (g) F1 15 0.205 0.017 0.174 0.197 0.208 0.218 0.228
F2 15 0.213 0.026 0.173 0.188 0.222 0.235 0.240
Relative uterine wt (%) F1 1 0.142
F2 1 0.112
Uterine weight (g) F1 1 0.068
F2 1 0.053
aExcludes 2 studies that did not cull to 4 pups/sex/litter on PND 4.
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Table 17
Control Values From the Scientific Literature: Individual Studies Reporting Reproductive Parameters in Sprague-Dawley
and Wistar Rats









Sprague-Dawley Sprague-Dawley Sprague-Dawley Wistar
Endpoint Gen. n Mean SD n Mean SD n Mean SD n Mean SD
Fertility index (%) (males) P1 30 90 28 100 27 92.6 25 96
P2 30 100 28 96.4 28 100 25 96
Fertility index (%) (females) P1 30 90 28 100 28 89.3 25 100
P2 30 100 28 96.4 28 100 25 100
Mating index (%) (males) P1 30 100 28 100 27 96.3 24 100
P2 30 96.7 28 96.4 28 100 24 100
Mating index (%) (females) P1 30 100 28 100 28 96.4 25 31.3 1.6
P2 30 96.7 28 96.4 28 100 32.9 2.7
Gestation index (%) P1 27 96.3 28 100 25 90.8 10.6
P2 29 100 27 96.3 93.5 10.9
Age at puberty onset (females) P1 25 43.6 1.2
P2 30 31.4 0.3 28 35.1 1.7 28 34.7 2.0 42.8 1.5
Body wt at puberty
onset (females)
P1 25 172.5 10.3
P2 30 108.25 2.50 28 118 16 28 128 16 165.5 8.9
Age at puberty onset (males) P1 25 677 133.7
P2 30 40.9 0.4 28 45.0 1.9 28 44.8 2.3 25 763 108.9
Body wt at puberty
onset (males)
P1 25 125 16.2
P2 30 208.17 2.28 28 228 27 28 235 24 25 119 11.5
Conc. epid. sperm
(106 sperm/g)
P1 30 946.71 20.94 25 88 11.0
P2 30 825.59 38.16 25 89 7.7
Conc. test. sperm.
(106 sperm./g testis)
P1 30 104.23 7.22 28 141 62 27 108 33 25 1.4 0.9
P2 30 47.22 6.12 28 127 46 28 122 43 25 1.3 1.1
Sperm motility (%) P1 30 77.6 1.0 28 77 8 27 76 8 25 96
P2 30 68.6 4.0 28 73 10 28 77 8 25 96
Abnormal sperm (%) P1 30 2.12 0.21 25 100
P2 30 5.99 3.18 25 100
Normal sperm (%) P1 28 96 3 27 96 3
P2 28 95 6 28 91 9
Ovarian follicle count (mean) P1 30 281.1 34.1
P2 30 368.4 26.3 25 224
Estrous cycle length (d) P1 30 4.39 0.20 25 4.1
P2 30 4.38 0.10 25 4.1
Time to mating (d) P1 30 3.1 0.6 24 2.6
P2 30 2.8 0.2 24 3.0
Gestational length (d) P1 26 22.2 0.1 28 22.6 0.4 26 22.8 0.5 24 22.1
P2 29 22.0 0.1 26 22.6 0.4 28 22.6 0.4 24 22.0
Postimplantation loss (%) P1 27 15.79 4.52 24 8.1
P2 29 10.02 1.21 24 8.8
Litter size, day 0 or 1 P1 26 13.3 0.9 28 14.4 3.2 25 14.3 3.2 24 11.0
P2 29 14.2 0.3 26 13.0 3.6 28 14.4 2.8 24 11.4
Sex ratio (% males) P1 28 52 25 48 24 46
P2 26 42 28 47 24 47
Anogenital distance,
male PND 0 (mm)
P1 26 2.06 0.03
P2 29 2.05 0.01
Body wt/litter,
male PND 0 (g)
P1 26 6.76 0.10
P2 29 6.63 0.11
Anogenital distance,
female PND 0 (mm)
P1 26 0.96 0.02
P2 29 0.98 0.01
Body wt/litter,
female PND 0 (g)
P1 26 6.35 0.10
P2 29 6.21 0.10
Male pup body wt, day 1 (g) P1 28 6.1 0.9 25 6.1 0.8
P2 26 6.5 1.0 28 6.2 0.7
Male pup body wt, day 21 (g) P1 28 51.8 6.6 25 53.4 7.5
P2 26 53.7 9.7 28 56.0 5.6
Female pup body wt, day 1 (g) P1 28 5.8 0.9 25 5.7 0.7
P2 26 5.9 0.8 28 5.8 0.6
Female pup body wt, day 21 (g) P1 28 49.6 7.1 25 51.9 7.5
P2 26 51.5 10.1 28 53.3 5.8
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Sprague-Dawley Sprague-Dawley Sprague-Dawley Wistar
Endpoint Gen. n Mean SD n Mean SD n Mean SD n Mean SD
Male adult organ weights
Terminal body weights (g) P1 30 599.25 9.46 28 600 81 27 639 71
P2 30 601.30 9.12 28 583 76 28 611 72
Relative adrenal wt (paired) (%)
a P1 30 0.0103 0.0003
P2 30 0.0097 0.0003
Adrenal wt (paired) (g) P1 30 0.0615 0.0017 28 0.061 0.010 27 0.054 0.013
P2 30 0.0583 0.0018 28 0.055 0.009 28 0.061 0.012
Relative brain wt (%) P1 30 0.365 0.005
P2 30 0.369 0.006
Brain wt. (g) P1 30 2.177 0.014 28 2.10 0.11 27 2.15 0.09
P2 30 2.205 0.016 28 1.99 0.14 28 2.18 0.09
Relative epididymal wt (paired) (%) P1 30 0.238 0.004 28 0.22 0.03 27 0.21 0.02
P2 30 0.226 0.006 28 0.22 0.03 28 0.22 0.03
Epididymal wt (paired) (g) P1 30 1.424 0.019 28 1.30 0.10 27 1.34 0.12
P2 30 1.351 0.028 28 1.24 0.10 28 1.32 0.10
Relative pituitary wt (%) P1 30 0.0028 0.0000
P2 30 0.0028 0.0001
Pituitary wt (g) P1 30 0.0169 0.0003
P2 30 0.0168 0.0003
Relative prostate wt (%) P1 30 0.142 0.006 28 0.10 0.03 27 0.10 0.03
P2 30 0.126 0.006 28 0.10 0.02 28 0.09 0.03
Prostate wt (g) P1 30 0.846 0.034 28 0.615 0.140 27 0.653 0.169
P2 30 0.756 0.037 28 0.554 0.130 28 0.600 0.198
Relative seminal vesicle wt (%) P1 30 0.396 0.010 28 0.43 0.08 27 0.39 0.05
P2 30 0.358 0.009 28 0.42 0.07 28 0.39 0.07
Seminal vesicle wt (g) P1 30 2.362 0.059 28 2.55 0.32 27 2.49 0.29
P2 30 2.145 0.052 28 2.39 0.32 28 2.35 0.30
Spleen wt (g) P1 28 0.879 0.117 27 0.864 0.132
P2 28 0.885 0.142 28 0.864 0.168
Relative testes wt (paired) (%) P1 30 0.578 0.010 28 0.63 0.09 27 0.60 0.07
P2 30 0.600 0.010 28 0.63 0.08 28 0.63 0.08
Testes wt (paired) (g) P1 30 3.447 0.058 28 3.72 0.26 27 3.84 0.42
P2 30 3.598 0.050 28 3.64 0.34 28 3.78 0.32
Thymus wt (g) P1 28 0.335 0.081 27 0.328 0.065
P2 28 0.390 0.101 28 0.364 0.096
Female adult organ weights
Terminal body wt (g) P1 29 342.21 3.76 27 354 30 24 351 28
P2 30 338.70 5.00 24 340 32 26 341 31
Adrenal wt (paired) (g) P1 27 0.089 0.014 24 0.088 0.017
P2 24 0.087 0.014 26 0.087 0.011
Brain wt (g) P1 27 1.94 0.09 24 1.95 0.20
P2 24 1.96 0.09 26 2.00 0.06
Relative ovary wt (paired) (%) P1 29 0.0495 0.0002 27 0.0341 0.0062 24 0.0315 0.0067
P2 30 0.043 0.001 24 0.0331 0.0044 26 0.0319 0.0041
Ovary wt (paired) (g) P1 29 0.153 0.007 27 0.120 0.021 24 0.110 0.022
P2 30 0.146 0.004 24 0.112 0.016 26 0.110 0.015
Spleen wt (g) P1 27 0.644 0.076 24 0.626 0.099
P2 24 0.690 0.079 26 0.663 0.092
Thymus wt (g) P1 27 0.215 0.066 24 0.228 0.059
P2 24 0.301 0.085 26 0.250 0.072
Relative uterine wt (%) P1 29 0.169 0.007 27 0.13 0.02 24 0.15 0.03
P2 30 0.169 0.006 24 0.15 0.04 26 0.15 0.04
Uterine wt (g) P1 29 0.575 0.021 27 0.46 0.08 24 0.53 0.11
P2 30 0.570 0.021 24 0.49 0.01 26 0.52 0.13
Male weanling organ weights
Terminal body wt (g) P1 68 49.45 1.24
P2 86 51.78 0.90
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be a more sensitive indicator of male reproductive
toxicity than fertility because of excess sperm produ-
ction in rats (Meistrich, 1989). Decreased sperm
production may be associated with decreased fertility,
decreased testicular weight (Blazak et al., 1993), or
testicular histopathologic changes, but this is not always
the case.
Sperm Morphology: Sperm morphology involves
the assessment of sperm for changes in shape of the tail,
head, or midpiece. It was considered a ‘‘high variability’’
endpoint as mean CVs were approximately 185% in
Sprague-Dawley rats and approximately 38% in Wistar
rats. When examining the distribution of sperm mor-
phology values, it appears that some atypically high
values (e.g., maximum percent abnormal sperm values of
15.9 and 30% in P1 and P2 Sprague-Dawley rats,
respectively) skewed the mean for percent abnormal
sperm. These high values may have resulted from
methodological differences across laboratories (Table 2).
For example, slide preparation can result in artifactual
increases in the percent abnormal sperm (Chapin and
Conner, 1999). Furthermore, laboratories are expected
to define the parameters for data collection such
that a reasonably sensitive assessment is conducted.
In the case of sperm morphology, the level of magnifica-
tion is not specified, but the minimum number of
sperm examined/male is defined as greater than or
equal to 200, with 500 sperm/male recommended, if
possible.
In rodents, background levels of abnormal sperm in
control mice and rats typically range from 0.3–6%
(Chapin and Conner, 1999). Thus, 475% of the Spra-
gue-Dawley values and all of the Wistar values are
within this previously reported range. Morphology is
considered a sensitive endpoint with which to detect
treatment-related effects because the probability of
detecting a doubling of abnormal sperm forms (e.g., 3
to 6%) is 90% when n 5 20 samples/group (Chapin and
Conner, 1999). Chapin et al. (1997) showed altered
fertility when sperm morphology alterations exceeded
10%, but it seems likely that when morphology altera-
tions achieved a certain threshold, decreases in sperm
count also could be noted due to multiple apoptotic
pathways in the rodent testis responsible for the
maintenance of sperm integrity (Sasagawa et al., 2001;
Stumpp et al., 2004). Sperm morphology alterations also
Table 17
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Sprague-Dawley Sprague-Dawley Sprague-Dawley Wistar
Endpoint Gen. n Mean SD n Mean SD n Mean SD n Mean SD
Relative brain wt (%) P1 68 2.987 0.061
P2 86 2.896 0.040
Brain wt (g) P1 68 1.450 0.010
P2 86 1.485 0.012
Relative spleen wt (%) P1 68 0.412 0.011
P2 86 0.406 0.009
Spleen wt (g) P1 68 0.205 0.009
P2 86 0.211 0.007
Relative thymus wt (%) P1 68 0.435 0.003
P2 86 0.454 0.009
Thymus wt (g) P1 68 0.215 0.007
P2 86 0.236 0.008
Female weanling organ weights
Terminal body wt (g) P1 73 47.86 1.10
P2 87 48.45 0.87
Relative brain wt (%) P1 73 3.007 0.056
P2 87 2.978 0.044
Brain wt (g) P1 73 1.419 0.012
P2 87 1.430 0.013
Relative spleen wt (%) P1 73 0.414 0.011
P2 87 0.404 0.008
Spleen wt (g) P1 73 0.200 0.009
P2 87 0.197 0.006
Relative thymus wt (%) P1 73 0.485 0.013
P2 87 0.493 0.010
Thymus wt (g) P1 73 0.232 0.008
P2 87 0.239 0.008
Relative uterine wt (%) P1 73 0.224 0.010
P2 87 0.164 0.007
Uterine wt (g) P1 73 0.108 0.006
P2 87 0.080 0.004
aOrgan weights relative to the terminal body weight in percent.
484 MARTY ET AL.
Birth Defects Research (Part B) 86:470–489, 2009
have been associated with decreased reproductive organ
weights, sperm motility changes, and altered testicular
histopathology (Chapin et al., 1985; Linder et al., 1988;
Gray et al., 1990); however, changes in sperm shape need
not be correlated with alterations in other sperm end-
points (Chapin and Conner, 1999; Morrissey et al., 1988).
Estrous Cycle Evaluation. Data on estrous cycle
length were within the expected range (e.g., 4–5 days)
across most studies that reported this endpoint. There
was slightly greater variability in Wistar rats, where
some control animals had cycles as short as 3.6 days.
While the typical estrous cycle in rats lasts 4–5 days,
there is a background incidence of altered estrous cycles
in rats, which can vary from 5% to 20–30% with some rat
strains or shipments (Cooper and Goldman, 1999). This
inter-animal variability may impact the sensitivity of this
endpoint to detect reproductive toxicants. Thus, estrous
cycle data are used to complement other data and do not
typically indicate an adverse effect alone (Cooper and
Goldman, 1999).
The Reproductive Health Effects test guideline states
that the test report should include ‘‘an analysis of P and
F1 female cycle pattern and mean estrous cycle length.’’
While estrous cycle length was frequently reported across
laboratories, estrous cycle pattern was either not reported
or reported in different manners, making it difficult to
determine typical evaluation and reporting practices. The
difficulty in reporting estrous cycle pattern may relate to
the lack of an agreed-upon method for evaluating estrous
cycles across a population (e.g., over the 3-week monitor-
ing period, is an animal’s cycle abnormal if it has 3
normal 4–5-day estrous cycles and 1 7-day cycle?). Cooper
and Goldman (1999) reported that estrous cycle pattern is
an important parameter in order to detect changes that
might be masked if only examining estrous cycle length.
Estrous cycle reporting is further complicated by the
brevity of estrus (E) and proestrus (P) stages in rats,
(typically 1–2 d and 0.5–1 d in duration, respectively;
Zarrow et al., 1964). These stages can be missed with
once-daily vaginal smears. The missing stages have to be
inferred to correctly assess cycle normalcy and duration.
Time to Mating and Gestational Length. Time
to mating (precoital interval) ranged from 1.8–4.4 and
2.4–4.0 days in first- and second-generation Sprague
Dawley rats, respectively. Similar intervals were seen in
Wistar rats (2.3–3.1 days for P1 animals and 1.9–3.4 days
for P2), indicating that the majority of animals mate
during the first estrous cycle.
Mean gestational length was reported in nearly all
laboratories. Across both strains, gestational length
ranged from 21.5–23.2 days with the majority of values
below 23 days. Altered gestational length may be
associated with or related to dystocia (difficulty in
delivering), litter size, altered postnatal survival rates,
and/or altered pup sex ratio and body weights, because
male rodents are heavier than female rodents from birth.
Primordial Follicle Counts. Quantitative follicle
counts are only required in P2 females, who have been
exposed to the test chemical during gestation, lactation,
and into adulthood. Primordial follicle counts were
among the most variable of the endpoints measured
across laboratories. In Sprague-Dawley-derived rats,
total primordial follicle counts varied from 10.7 versus
384.0 per sample. The mean primordial follicle count
across studies was 116.2780.1 (X7SD). Slightly less
variability was noted in Wistar-derived rats with a range
of 64.0 to 250.0 for total primordial follicle counts
(mean 5 173.2749.8).
There are numerous factors that may have contributed
to the variability across laboratories. For example,
different sampling methods likely contribute to this
variability as the number of animals, number of sections,
and the selection of ovarian sections for examination are
not specified in the current EPA OPPTS or OECD
guidelines (US EPA OPPTS, 1998; OECD, 2001), and
therefore vary across laboratories (Regan et al., 2005). The
test guideline required each laboratory to establish a
procedure that was ‘‘statistically valid’’ based on
references describing this procedure in mice (Bolon
et al., 1997; Bucci et al., 1997) with some guidance (e.g.,
Heindel, 1999) as to how to apply these practices to rats.
With each laboratory defining its own procedure, some
variability between laboratories was not unexpected.
However, greater variability was attributed to inherent
biological differences (Table 2). There is inherent intra-
and inter-animal variability in the ovarian follicle pool.
Bucci et al. (1997) reported 30–40% variability in follicle
counts between ovaries taken from the same mice with
even greater variability between ovaries from different
animals. Thus, large variability between individuals and
groups has been reported with primordial follicle counts,
making interpretation of follicle count data difficult.
Furthermore, quantification of primordial follicles in the
F1 females is very time-consuming and expensive. The
Society of Toxicologic Pathology has recommended that
quantification of primordial follicles be reserved for a
Tier 2 evaluation of ovarian effects and triggered in each
case based on qualitative histopathology data as well as
data from other reproductive endpoints (Regan et al.,
2005). This recommendation is supported by the inherent
variability in the current data set. As part of this Tier 2
assessment, a full spectrum count of the various follicular
stages would provide more useful data to interpret
changes in the number of primordial follicles.
Reproductive Organ Weights. Male and female
reproductive organ weights, relative and absolute, are
presented in Tables 7 (Sprague-Dawley rats) and 8
(Wistar rats), respectively. With bilateral organs (e.g.,
testes), some laboratories presented unilateral weights;
thus, values in Tables 7 and 8 represent unilateral
weights either as reported or derived (half of bilateral
weights). Overall, CVs were relatively low for reproduc-
tive organ weights. Variability was likely related to
differences in age/body weight at the time of necropsy,
relatively minor differences in dissecting/trimming
techniques, and/or inherent biological variability. Testis
Weights: Differences in sperm production rate often are
associated with alterations in testis weight. Furthermore,
testis weights in rats have some inherent variability that
appears to be independent of spermatogenesis (Blazak
et al., 1985; Robb et al., 1978). Even within the normal
physiological range, levels of androgen production vary
between male rats, which may contribute to variability in
other androgen-dependent reproductive organ weights.
Prostate Weights: The prostate is composed of dorsolateral
and ventral lobes, with different profiles (numbers and
distribution pattern) of androgen (AR) and estrogen (ER)
receptors and, therefore, with different susceptibilities
and responsiveness. The prostate is, therefore, weighed
whole or with the lobes separated, whereby a total
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weight can be derived from the separate lobe weights.
Absolute and relative prostate weights in Sprague-
Dawley rats were designated as a ‘‘high variability’’
endpoint with CVsZ29%. Given that variability was
lower in the Wistar studies (CVo14% with fewer studies
collected in fewer laboratories), it is possible that either
strain differences and/or inter-laboratory differences in
dissecting techniques contributed to this variability.
Notably, a relatively large inter-animal variability in
prostate weights has been documented (Elswick et al.,
2000) and the variability analysis (Table 2) supports some
inter-animal variability in this endpoint in P2 males.
Seminal Vesicle Weights: The seminal vesicles are usually
weighed with coagulating glands (and their fluids) as a
single unit. Variability in seminal vesicles weights
may be related to differences in the production of
seminal fluid. In addition, loss of some fluid during
dissection may contribute to some variability in
seminal vesicle weights. To avoid this, some laboratories
weigh the prostate and seminal vesicles together to
prevent seminal fluid loss, then remove the prostate
and weigh it separately. The seminal vesicle weight is
then determined by subtraction. Ovarian and Uterine
Weights: A likely contributor to differences in female
reproductive organ weights is the stage of the estrous
cycle during necropsy. The current US EPA OPPTS
(1998) and OECD (2001) guidelines do not require
that all females be euthanized during the same stage
of the estrous cycle; rather, a determination of estrous
stage at the time of necropsy can be used to explain
terminal differences in hormone-influenced endpoints.
In addition, collection of wet (imbibed) and blotted
uterine weights can address some issues related to
variability.
Non-Reproductive Organ Weights. Weights for
adrenal glands, brain, pituitary, spleen, thymus. and
thyroid glands in P1 and P2 adult animals appear in
Tables 9A, 9B (male and female Sprague-Dawley rats)
and 10A, 10B (male and female Wistar rats). Across
organs and strains, CVs were r20% for all organ weights
with the exception of relative brain weights in P2
Sprague-Dawley males and thymus weights. The relative
brain weight in P2 males had a CV of 22%, despite low
CVs (r9%) for other brain weight measurements in
Sprague-Dawley adult males (i.e., P1 absolute and
relative brain weights and P2 absolute brain weights).
This variance may be a reflection of relatively stable
absolute brain weights in the presence of variable
terminal body weights. Absolute and relative thymus
weights were considered ‘‘highly variable’’ endpoints as
CVs ranged from 25–42% in male rats of both strains and
approximately 31% in the second-generation female
Sprague-Dawley rats. Interestingly, the CVs were r17%
for absolute and relative thymus weights for female
Wistar rats and first-generation female Sprague-Dawley
rats. The reason for the variability in thymus weights is
not known, but both intra- and inter-laboratory factors
contribute to this variability (Table 2). Relative organ
weight parameters are affected by and dependent on
terminal body weight (i.e., a ‘‘normal’’ or significantly
reduced absolute organ weight and a reduced body
weight can result in a significantly increased relative
organ weight). Dr. J. Haseman (NIEHS) has suggested
that for an organ weight change to be considered ‘‘real.’’
both the absolute and relative weights of that organ have
to be significantly different and both in the same
direction (both increased or both decreased).
Litter size. Data for litter sizes are presented in
Tables 11 (Sprague-Dawley rats) and 12 (Wistar rats). For
Sprague-Dawley rats, data are separated into litters that
were standardized (i.e., culled) or not standardized; all
litters were standardized in the Wistar studies. While
indices of birth, viability, lactation, and offspring sex
ratio are mentioned in the test guideline, these indices
often were not reported as independent values in the
studies submitted. While some laboratories reported live-
birth and survival indices, these variables were reported
so infrequently that it was not appropriate to present
control data from such small sample sizes. It is possible
that laboratories rely on litter size to evaluate live birth
rates and survival, making litter size a more robust value
for inclusion in this inter-laboratory data set. Litter sizes,
sex ratio (% males/litter), and body weights per sex per
litter should be collected and reported frequently
throughout lactation to detect not just an effect on these
parameters, but when this change(s) occurred. From the
submitted data, it appears that Sprague-Dawley rats
have larger litters than Wistar rats (mean values of B13.6
vs. B11.7 pups on PND 0, respectively, when comparing
data from litters that were subsequently culled). Based
on litter size measurements, pup survival appeared to be
similar between the two strains.
Pup Body Weights and Anogenital Distance.
Sprague-Dawley and Wistar pup body weights and
anogenital distance appear in Tables 13 and 14, respec-
tively. Aside from slightly smaller litter sizes, Wistar
pups also weigh slightly less than Sprague-Dawley pups.
The sample size for anogenital distance (AGD)
measurements is less than other endpoints, because
AGD is a triggered endpoint in the second-generation
(F2) offspring, and therefore, not reported in all studies.
Triggers for AGD include a change in sex ratio or puberty
onset in the F1/P2 offspring. AGD measurements differ
by pup age, and AGD was measured on different days
across laboratories (i.e., postnatal days 0–4). Data in
Tables 13 and 14 reflect AGD measurements collected on
PND 1 (day of birth 5 PND 0). AGD was considered
a ‘‘high variability’’ endpoint with CVs ranging from
28–42%. Some of this variability can be attributed to the
difficulty in accurately measuring small distances as well
as the low sample size (n 5 9) included in this analysis.
Furthermore, pup size/body weight also can affect AGD
measurements (Gallavan et al., 1999) and some labora-
tories failed to report body weight at the time AGD was
collected. In laboratories reporting body weight, differ-
ent methodologies were used to adjust for body weight
differences, although cubed root of body weight was
most frequently used (Gallavan et al., 1999). With these
inter-laboratory differences, it was difficult to accurately
determine a mean control value for relative AGD
measurements. One laboratory also reported AGD
measurements in the first-generation (F1) offspring,
which may be advantageous for subsequent interpreta-
tion of F1/P2 endpoints and comparison with the F2 data
(Tyl et al., 2004).
Pup Organ Weights. According to the OPPTS
870.3800 guidelines, brain, spleen, and thymus weights
in weanling rats are required. These organ weights are
reported in Tables 15 (Sprague-Dawley rats) and 16
(Wistar rats). Uterine weight in weanling females is not
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required by EPA OPPTS 870.3800 or OECD 416, but is
required per Japan’s Ministry of Agriculture, Forestry
and Fisheries (JMAFF) testing guidelines as of 2002. With
the exception of weanling uterine weights, CVs were
r16% for all pup organ weights. Absolute and relative
uterine weights were considered ‘‘highly variable’’ end-
points as CVs ranged from 16–52% in weanling female
Sprague-Dawley rats. This high variability is likely
related to the low sample size for this endpoint (n 5 3
for Sprague-Dawley rats), although differences in the
onset of endogenous estrogen secretion also could
contribute to this variability.
Strain Differences: Sprague-Dawley Versus
Wistar
Throughout Tables 3–16, control values for Sprague-
Dawley and Wistar rats appear to be similar, although in
many cases, Wistar data were less variable. This may
reflect the number of laboratories that contributed to the
respective data sets, because nine companies contributed
to the Sprague-Dawley data, whereas the Wistar data
originated from only two companies. With respect to
male reproductive parameters, Sprague-Dawley rats
were noted to have heavier seminal vesicle weights than
Wistar rats in the present dataset, a finding that was
reported previously (Wilkinson et al., 1999). Wilkinson
et al. (1999) also reported greater epididymal sperm
counts in Sprague-Dawley rats, which was not confirmed
in the current data set.
The Use of Inter-Laboratory Vehicle Control Data
These inter-laboratory vehicle control data are pro-
vided to allow laboratories to examine their mean control
values in the context of mean control values obtained at
other laboratories. With these data, laboratories may gain
some assessment of whether their procedures for
measuring endpoints are appropriate and if their mean
values fall within or outside of the range of values
typically obtained for a given endpoint. These data also
illustrate endpoints having greater variability due to
either inherent variability and/or methodological differ-
ences in endpoint assessment across laboratories. It is
important to note that while there is a normal range for
most parameters, mean control values may periodically
fall outside this range due to chance (at P 5 0.05, there is
the recognition that one in 20 significant differences is, in
fact, due to chance, i.e., a type I error). Thus, these inter-
laboratory control data may be useful in interpreting data
from treated animals when a control value is aberrant.
However, these data are not intended to supplant each
laboratory’s own historical control data.
When presenting the inter-laboratory control data, the
committee agreed to present the mean (mean of study
means) and SD, as well as the minimum, 25th, 50th, 75th
percentile, and maximum of all mean values reported for
each endpoint. It was thought that these values accu-
rately convey the distribution of mean data for each
endpoint across studies; however, the committee mem-
bers felt that values for some endpoints exceeded the
range of biologically plausible variability. Thus, caution
should be exercised when using some values at the
extremes of the distribution to interpret multi-generation
study data, because some variables include maximum
control values that overlap with potential treatment-
related effects (e.g., 30% abnormal sperm).
When a laboratory’s values for specific endpoints are
consistently outside the ranges reported (or frequently
located on the peripheral ranges of the distribution), a
review of laboratory procedures may be warranted. In
the event that a laboratory is confident that their
practices are scientifically valid and sufficiently sensitive
to detect compound-mediated changes, the laboratory
must rely on its own historical control data. For some
highly variable endpoints, performance criteria may be
needed.
Missing Data
Interestingly, control data were not reported for all
endpoints in all 44 of the submitted reports. There are
three possible explanations to explain these missing data
points: (1) the endpoints were examined, but the data
were not reported, (2) the endpoints were examined, but
the data were reported in a different format, or (3) the
endpoints were not evaluated in all of the submitted
studies.
The possibility that endpoints were examined but the
data were not reported would not be surprising. To
compile the data for analyses, companies were asked to
submit the report text and the summary tables of the
study results. Due to the size of each multi-generation
study report, individual animal data and appendices for
the reports were typically not requested. Thus, if values
for a specific endpoint were omitted from the report text
or summary tables, these data would be absent in the
dataset. In an effort to minimize the amount of missing
data, data gaps were identified and the text of the report
was reviewed for evidence that the endpoint in question
was examined in the submitting laboratory. If the
endpoint was mentioned in the text, the laboratory was
contacted and asked to provide the missing data (e.g.,
submission of individual animal data, if needed).
However, in many cases, the missing endpoint(s) were
not mentioned in the text. It is possible that these data
were collected, but in the absence of treatment-related
effects, the data for all endpoints were not presented in
either the text or summary tables, depending on the
practice of each laboratory.
In some cases, the endpoints may have been examined,
but the data were reported in a different manner. For
example, instead of presenting ‘‘mean estrous cycle
length,’’ some laboratories report the ‘‘number or percent
of females with normal/abnormal cycles’’; thus, while
these laboratories evaluated the estrous cycle, they
reported it in a manner that was not readily incorporated
into this analysis. In actuality, both mean cycle duration
and numbers (and types) of abnormal cycles within
the evaluation period are useful to better characterize
female cyclicity. ‘‘Days to mating’’ could be reported as
the ‘‘number of animals mating during different cycle
intervals’’ (e.g., number mated during the first cycle on
days 1–4, the second cycle on days 5–8, etc.). Some
laboratories report ‘‘number of implantations’’ and ‘‘live
litter size on day 0’’ as opposed to ‘‘percent postimplan-
tation loss.’’ Epididymal sperm concentration could be
reported as ‘‘number of sperm per sample volume’’ (e.g.,
107 sperm/ml) as opposed to per g epididymal tissue
weight, which would still allow comparison of sperm
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concentrations across treatment groups, assuming that
the same sample volume was used for each sample. An
estimate of sperm count/g cauda epididymal tissue
could be derived using the individual cauda epididymal
weights associated with each male’s sperm count
(preferred method as it is most accurate), using each
whole epididymis weight if the cauda were not weighed
separately (less accurate), or using the mean cauda or
mean epididymal weights, although there would be
imprecision in this calculated value. Overall, these
examples illustrate different practices by which data on
the same functional parameters may be reported. Thus,
these studies may, in fact, provide the necessary data to
assess effects on the reproductive system, but due to
formatting differences, these data were not amenable for
entry into the database. In appropriate cases, some
values were derived from the data reported in an
alternate format (e.g., percent abnormal sperm based
on the percent normal sperm, unilateral organ weights
based on bilateral organ weights, etc.).
It also is possible that some endpoints were not
examined in all laboratories. Some endpoints are trig-
gered based on other results in the study (e.g., anogenital
distance); therefore, if the triggering criteria were not met,
these endpoints may not be included in a given study.
Some reports from 1997 and 1998 also were included in
the database. These early reports were likely initiated
prior to finalizing the test guidelines in 1998, and, thus,
may not have included all endpoints. Furthermore, the
test guidelines may be interpreted differently by different
laboratories, such that some laboratories collected all
‘‘suggested’’ endpoints, whereas other laboratories did
not. Lastly, it is possible that laboratories chose not to
collect and/or report all required endpoints.
Despite some data gaps where data for each endpoint
were not received from every laboratory, the sample sizes
for the inter-laboratory control values were reasonable.
Thus, the steering committee felt that the mean values were
a reasonable representation of control means in most cases.
Comparison With Other Published Studies
To further evaluate the inter-laboratory control data
set, data were compared with reproductive toxicity data
reported in the scientific literature. Table 17 shows data
from 4 reproductive toxicity studies that were used for
this comparison. The published data from these studies
were evaluated against the database to insure that these
studies were not included in the inter-laboratory control
data set. Overall, the data in the inter-laboratory control
data set were comparable to the values reported in the
scientific literature.
CONCLUSIONS
This work presents a compilation of inter-laboratory
control data that can be used by investigators to examine
variability in reproductive endpoint values. For endpoint
values identified as highly variable, further considera-
tion should be given to identifying and limiting potential
source(s) of the variability. Procedural variability may be
due to: Presence/absence of SOPs; inter-laboratory
differences in SOPs; differences in training, experience,
and/or equipment; inter-technician variability in data
collection (are technicians ‘‘blind’’ to treatment group?);
time of day for data collection; and order of data
collection (i.e., are they distributed across dose groups
rather than completing collection in each dose group
sequentially?). These inter-laboratory control data also
provide a means for laboratories to review their
performance on reproductive toxicity measures, as well
as providing some perspective for interpreting their own
control data and data from treated animals.
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